FDA Inspection 809111 — Intersect ENT, Inc.

Intersect ENT, Inc. — FEI 3008301917

The FDA completed an inspection of Intersect ENT, Inc. on Dec 11, 2012 in Menlo Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 11, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Menlo Park, CA (United States)

Citations

IDCFRDescription
317221 CFR 820.198(c)Investigation of device failures
73121 CFR 803.50(a)(1)Report of Death or Serious Injury

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.